Genomic Health, Inc. (NASDAQ: GHDX) reported Q1 EPS of $0.02, $0.05 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $58.58 million versus the consensus estimate of $56.27 million.

For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.

Earnings